Diabetes Scorecard Educational Intervention Study
Use of a Card to Improve Risk Factor Control in Patients With Type II Diabetes
1 other identifier
interventional
104
1 country
1
Brief Summary
The purpose of this study is to see if the use of a diabetic scorecard during clinic visits can improve glycemic control, blood pressure control, LDL-cholesterol, aspirin usage, and amount of exercise in adults over age 40 with uncontrolled Type II diabetes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable type-2-diabetes
Started Nov 2008
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2010
CompletedFirst Submitted
Initial submission to the registry
April 19, 2011
CompletedFirst Posted
Study publicly available on registry
April 20, 2011
CompletedAugust 11, 2017
August 1, 2017
1.5 years
April 19, 2011
August 10, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Change in total score
The total score was calculated by points assigned to variables (systolic blood pressure, diastolic blood pressure, HbA1c, aspirin usage and daily exercise). The maximal score of 100 corresponds to all variables at target. Fewer points were assigned to higher blood pressure, worse HbA1c levels, less exercise, etc.
9 months
Secondary Outcomes (2)
LDL-cholesterol
9 months
HbA1c
9 months
Study Arms (2)
Scorecard
EXPERIMENTALScore of points for variables.
Control
NO INTERVENTIONStandard of care for diabetes subjects
Interventions
Eligibility Criteria
You may qualify if:
- Uncontrolled Type II diabetes (HbA1c ≥ 8%)
You may not qualify if:
- Type I Diabetes
- HbA1c \< 8%
- Inability to understand the diabetes scorecard due to condition (i.e. dementia, mental retardation, etc) or language barrier
- Pregnancy
- Planning to move within the next year
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Medical Faculty Associates, George Washington University
Washington D.C., District of Columbia, 20037, United States
Related Publications (1)
Irwig MS, Sood P, Ni D, Amass T, Khurana PS, Jayanthi VV, Wang L, Adler SM. A diabetes scorecard does not improve HbA(1c), blood pressure, lipids, aspirin usage, exercise and diabetes knowledge over 9 months: a randomized controlled trial. Diabet Med. 2012 Sep;29(9):1206-12. doi: 10.1111/j.1464-5491.2012.03610.x.
PMID: 22332914DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Attending Physician
Study Record Dates
First Submitted
April 19, 2011
First Posted
April 20, 2011
Study Start
November 1, 2008
Primary Completion
May 1, 2010
Study Completion
May 1, 2010
Last Updated
August 11, 2017
Record last verified: 2017-08